252 related articles for article (PubMed ID: 24038728)
1. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
[TBL] [Abstract][Full Text] [Related]
2. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
4. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder.
Dutcher CD; Dowd SM; Zalta AK; Taylor DJ; Rosenfield D; Perrone A; Otto MW; Pollack MH; Hofmann SG; Smits JAJ
Depress Anxiety; 2021 Nov; 38(11):1182-1190. PubMed ID: 34010494
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
[TBL] [Abstract][Full Text] [Related]
6. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
8. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
9. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
[TBL] [Abstract][Full Text] [Related]
10. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Scheeringa MS; Weems CF
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
[TBL] [Abstract][Full Text] [Related]
12. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011565. PubMed ID: 26968204
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of exposure therapy with post-session administration of D-cycloserine.
Tart CD; Handelsman PR; Deboer LB; Rosenfield D; Pollack MH; Hofmann SG; Powers MB; Otto MW; Smits JA
J Psychiatr Res; 2013 Feb; 47(2):168-74. PubMed ID: 23098672
[TBL] [Abstract][Full Text] [Related]
14. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
Roque AD; Rosenfield D; Smits JAJ; Simon N; Otto MW; Marques L; Pollack MH; Hofmann SG; Meuret AE
J Anxiety Disord; 2018 Jan; 53():85-90. PubMed ID: 29227845
[TBL] [Abstract][Full Text] [Related]
15. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases.
Kappelmann N; Suesse M; Steudte-Schmiedgen S; Kaldewaij R; Browning M; Michael T; Rinck M; Reinecke A
J Behav Ther Exp Psychiatry; 2020 Sep; 68():101546. PubMed ID: 31951819
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
Blanco C; Heimberg RG; Schneier FR; Fresco DM; Chen H; Turk CL; Vermes D; Erwin BA; Schmidt AB; Juster HR; Campeas R; Liebowitz MR
Arch Gen Psychiatry; 2010 Mar; 67(3):286-95. PubMed ID: 20194829
[TBL] [Abstract][Full Text] [Related]
17. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
[TBL] [Abstract][Full Text] [Related]
18. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
[TBL] [Abstract][Full Text] [Related]
19. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
Smits JA; Hofmann SG; Rosenfield D; DeBoer LB; Costa PT; Simon NM; O'Cleirigh C; Meuret AE; Marques L; Otto MW; Pollack MH
J Consult Clin Psychol; 2013 Dec; 81(6):1100-12. PubMed ID: 23937345
[TBL] [Abstract][Full Text] [Related]
20. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
Diminich ED; Dickerson F; Bello I; Cather C; Kingdon D; Rakhshan Rouhakhtar PJ; Hart KL; Li C; Troxel AB; Goff DC
Schizophr Res; 2020 Aug; 222():145-152. PubMed ID: 32591238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
